leon-nanodrugs

THE FUTURE OF NANO ENCAPSULATION

Add To Watchlist
General Information
Company Name
leon-nanodrugs
Founded Year
2011
Location (Offices)
Munchen, Germany +2
Founders / Decision Makers
Wolfgang Beier - CSO Andrea Cusack - Managing Director and Chief Business Officer Cornelia Beier - Co-founder Christian Nafe - Managing Director and Chief Financial Officer
Number of Employees
11
Industries
Biotechnology, Health Care, Pharmaceutical
Funding Stage
Series B
Social Media

leon-nanodrugs - Company Profile

Leon Nanodrugs

Leon Nanodrugs, with the slogan "THE FUTURE OF NANO ENCAPSULATION," is a biotechnology company founded in 2011 in Germany. The company specializes in the encapsulation of nucleic acids, biomolecules, and other APIs, offering solutions for encapsulation challenges and providing flexible GMP manufacturing solutions for genetic payloads and other molecules. Their proprietary nano technology platform allows for the continuous manufacturing of SMART nanoparticles, including surface stabilized polymeric, lipid nanoparticles (LNP's) and liposomes.

The Company has secured a Series B investment on 16 April 2020 from a group of notable investors including Evotec, TVM Capital Life Science, BayBG VENTURE CAPITAL, Eckenstein-Geigy Stiftung, Albany Capital, CD-Venture, and LOF Leon Partnership. They are also collaborating with world-class industry partners for process and product development in the biotechnology, healthcare, and pharmaceutical sectors.

Taxonomy: Nanoencapsulation, Nucleic acids, Biomolecules, APIs, GMP manufacturing, Genetic payloads, Transfection material, Nanotechnology, Polymeric nanoparticles, Lipid nanoparticles, Liposomes, Process development, Product development, Pharmaceuticals

Funding Rounds & Investors of leon-nanodrugs (2)

View All
Funding Stage Amount No. Investors Investors Date
Series B Unknown 7
Evotec, investor in leon-nanodrugs's Series B round TVM Capital Life Science, investor in leon-nanodrugs's Series B round BayBG VENTURE CAPITAL, investor in leon-nanodrugs's Series B round Eckenstein-Geigy Stiftung, investor in leon-nanodrugs's Series B round Albany Capital, investor in leon-nanodrugs's Series B round
CD-Venture, LOF Leon Partnership 		16 Apr 2020
Series A €18.50M 3
TVM Capital Life Science, investor in leon-nanodrugs's Series A round
LifeCare Partners, Signet Healthcare Partners 		27 Jul 2015

Latest News of leon-nanodrugs

View All

No recent news or press coverage available for leon-nanodrugs.

Similar Companies to leon-nanodrugs

View All
ETC Solar - Similar company to leon-nanodrugs
ETC Solar Mesoline pioneers a scalable platform, redefining semiconductor manufacturing with precise 3D microstructures through advanced nanomaterial deposition.
NanoCarrier Ltd. - Similar company to leon-nanodrugs
NanoCarrier Ltd.
20Med Therapeutics - Similar company to leon-nanodrugs
20Med Therapeutics Innovative polymer nanoparticle technology for the development of RNA and DNA based therapeutics and vaccines!
Advanced Nanotechnologies - Similar company to leon-nanodrugs
Advanced Nanotechnologies Advanced Nanotechnologies is devoted to providing high-quality materials & surface applications based on nanotechnology
Quantum Materials Corp - Similar company to leon-nanodrugs
Quantum Materials Corp Trust the Light... Bonding the physical and the digital
Circle Decoration Circle Decoration

Want to dive deeper into leon-nanodrugs? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now